Clinical Relevance of HLA Antibodies in Kidney Transplantation: Recent Data from the Heidelberg Transplant Center and the Collaborative Transplant Study

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/jir/volume-2017/5619402/figures/5619402.fig.001a.svgz" name="5619402.fig.001a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>Heidelberg 2000–2007</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/jir/volume-2017/5619402/figures/5619402.fig.001b.svgz" name="5619402.fig.001b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>Heidelberg after 2007</td></tr></table>

<div>Graft survival in patients with and without ELISA-reactive HLA antibodies who were transplanted at the Heidelberg Transplant Center between 2000 and 2007 (a) and after 2007 (b). Ab: ELISA-reactive HLA antibody.</div>

Journal of Immunology Research

fig1

Figure 1

Figure 1: Clinical Relevance of HLA Antibodies in Kidney Transplantation: Recent Data from the Heidelberg Transplant Center and the Collaborative Transplant Study 

Figure 1 | Clinical Relevance of HLA Antibodies in Kidney Transplantation: Recent Data from the Heidelberg Transplant Center and the Collaborative Transplant Study 